Rocket Pharma: John Militello resigns as Principal Accounting Officer; Joseph Manhede appointed

ROCKET PHARMACEUTICALS, INC.

John Militello resigns as VP Finance, Senior Controller, Treasurer and Principal Accounting Officer effective July 7, 2026 to pursue other opportunities.
Joseph Manhede, age 48, appointed as Principal Accounting Officer effective July 8, 2026; previously Associate VP Corporate Controller since April 2026.
Manhede previously held senior finance roles at Outlook Therapeutics, Amneal Pharmaceuticals, Unilife, and Celator; began career at Deloitte as Audit Manager.
No new compensatory arrangements entered into with Manhede in connection with the appointment; no family relationships or reportable transactions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.